Eliel Nham

404 total citations
38 papers, 200 citations indexed

About

Eliel Nham is a scholar working on Infectious Diseases, Epidemiology and Health. According to data from OpenAlex, Eliel Nham has authored 38 papers receiving a total of 200 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Infectious Diseases, 14 papers in Epidemiology and 9 papers in Health. Recurrent topics in Eliel Nham's work include SARS-CoV-2 and COVID-19 Research (14 papers), COVID-19 Clinical Research Studies (11 papers) and Vaccine Coverage and Hesitancy (9 papers). Eliel Nham is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (14 papers), COVID-19 Clinical Research Studies (11 papers) and Vaccine Coverage and Hesitancy (9 papers). Eliel Nham collaborates with scholars based in South Korea, Japan and United States. Eliel Nham's co-authors include Hee Jin Cheong, Woo Joo Kim, Joon Young Song, Ji Yun Noh, Jin Gu Yoon, Hye Seong, Kyungmin Huh, Cheol‐In Kang, Sun Young Cho and Hakjun Hyun and has published in prestigious journals such as The Journal of Infectious Diseases, Frontiers in Immunology and Medicine.

In The Last Decade

Eliel Nham

35 papers receiving 198 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eliel Nham South Korea 8 107 49 32 30 20 38 200
Costanza Di Chiara Italy 10 135 1.3× 35 0.7× 13 0.4× 46 1.5× 16 0.8× 33 246
Felix Buder Germany 7 135 1.3× 40 0.8× 12 0.4× 37 1.2× 13 0.7× 9 231
Deblina Datta United States 6 81 0.8× 91 1.9× 54 1.7× 32 1.1× 8 0.4× 11 196
Nicola Schiano Moriello Italy 11 159 1.5× 104 2.1× 13 0.4× 31 1.0× 14 0.7× 27 266
Cathy Qi United Kingdom 8 86 0.8× 75 1.5× 10 0.3× 19 0.6× 37 1.9× 13 259
Burcu Ceylan Cura Yayla Türkiye 9 165 1.5× 43 0.9× 16 0.5× 41 1.4× 17 0.8× 21 253
Hussam Kawas Qatar 3 184 1.7× 20 0.4× 77 2.4× 40 1.3× 12 0.6× 3 257
Serge Ouoba Japan 9 84 0.8× 144 2.9× 10 0.3× 55 1.8× 21 1.1× 34 346
Maria Overvad Denmark 6 151 1.4× 32 0.7× 35 1.1× 8 0.3× 44 2.2× 11 242
Francesc Barbosa Spain 9 89 0.8× 58 1.2× 12 0.4× 9 0.3× 9 0.5× 19 207

Countries citing papers authored by Eliel Nham

Since Specialization
Citations

This map shows the geographic impact of Eliel Nham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eliel Nham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eliel Nham more than expected).

Fields of papers citing papers by Eliel Nham

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eliel Nham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eliel Nham. The network helps show where Eliel Nham may publish in the future.

Co-authorship network of co-authors of Eliel Nham

This figure shows the co-authorship network connecting the top 25 collaborators of Eliel Nham. A scholar is included among the top collaborators of Eliel Nham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eliel Nham. Eliel Nham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Song, Joon Young, Seong‐Heon Wie, Jacob Lee, et al.. (2025). Interim Vaccine Effectiveness Against Influenza and Hospitalization, Republic of Korea, 2024–2025 (HIMM Network). Vaccines. 13(11). 1100–1100.
2.
Nham, Eliel, Joon Young Song, Jang Wook Sohn, et al.. (2025). Real-world effectiveness of COVID-19 XBB.1.5 monovalent mRNA vaccine: Analysis over nine months. Vaccine. 59. 127275–127275. 1 indexed citations
3.
Nham, Eliel, Hye Seong, Jin Gu Yoon, et al.. (2024). Erythema nodosum as an unusual skin manifestation of long COVID: A case report. International Journal of Infectious Diseases. 146. 107152–107152.
4.
Seong, Hye, Jin Gu Yoon, Eliel Nham, et al.. (2024). The gut microbiota modifies antibody durability and booster responses after SARS-CoV-2 vaccination. Journal of Translational Medicine. 22(1). 827–827. 4 indexed citations
5.
Nham, Eliel, Si‐Ho Kim, J.H. Ko, et al.. (2024). Diagnostic performance of the (1-3)-β-d-glucan assay in patients with different risks for invasive fungal diseases. Medical Mycology. 62(8). 1 indexed citations
6.
Nham, Eliel, Jin Gu Yoon, Min Joo Choi, et al.. (2024). Establishment of Safety Monitoring System for Vaccines Not Included in the National Immunization Program in Korea. Journal of Korean Medical Science. 39(5). e45–e45. 1 indexed citations
7.
Sohn, Jang Wook, Won Suk Choi, Seong‐Heon Wie, et al.. (2024). Interim Estimates of 2023–2024 Seasonal Influenza Vaccine Effectiveness Among Adults in Korea. Journal of Korean Medical Science. 39(15). e146–e146. 6 indexed citations
8.
Hyun, Hakjun, Eliel Nham, Hye Seong, et al.. (2024). Long-term humoral and cellular immunity against vaccine strains and Omicron subvariants (BQ.1.1, BN.1, XBB.1, and EG.5) after bivalent COVID-19 vaccination. Frontiers in Immunology. 15. 1385135–1385135. 3 indexed citations
9.
Jung, Jaehun, Minsun Kang, Min Joo Choi, et al.. (2024). The risk of pregnancy-related adverse outcomes after COVID-19 vaccination: Propensity score-matched analysis with influenza vaccination. Vaccine. 44. 126506–126506. 2 indexed citations
10.
Nham, Eliel, Eyun Song, Hakjun Hyun, et al.. (2023). Concurrent Subacute Thyroiditis and Graves’ Disease After COVID-19: A Case Report. Journal of Korean Medical Science. 38(18). e134–e134. 5 indexed citations
11.
Yoon, Jin Gu, Jang Wook Sohn, Won Suk Choi, et al.. (2023). Effectiveness of Bivalent mRNA Booster Vaccine Against COVID-19 in Korea. Journal of Korean Medical Science. 39(3). e15–e15. 1 indexed citations
12.
Nham, Eliel, Jungmin Lee, Heedo Park, et al.. (2023). Low Neutralizing Activities to the Omicron Subvariants BN.1 and XBB.1.5 of Sera From the Individuals Vaccinated With a BA.4/5-Containing Bivalent mRNA Vaccine. Immune Network. 23(6). e43–e43. 5 indexed citations
13.
14.
Nham, Eliel, Doo Ryeon Chung, Jungok Kim, et al.. (2023). Effect of a latent tuberculosis infection programme for healthcare workers in a country with an intermediate tuberculosis burden. Journal of Hospital Infection. 154. 104–111. 1 indexed citations
15.
Choi, Min Joo, Hakjun Hyun, Eliel Nham, et al.. (2023). Comparative safety analysis of mRNA and adenoviral vector COVID-19 vaccines: a nationwide cohort study using an emulated target trial approach. Clinical Microbiology and Infection. 30(5). 646–652. 6 indexed citations
16.
Seong, Hye, Jun Hyoung Kim, Ho Seong Seo, et al.. (2023). Clinical implications of gut microbiota and cytokine responses in coronavirus disease prognosis. Frontiers in Immunology. 14. 1079277–1079277. 3 indexed citations
17.
Nham, Eliel, Kyungmin Huh, Hyo Jung Park, et al.. (2022). Pharmacokinetic/pharmacodynamic parameters of vancomycin for predicting clinical outcome of enterococcal bacteremia. BMC Infectious Diseases. 22(1). 686–686. 10 indexed citations
18.
Ko, Jae‐Hoon, Soyoung Ha, Eliel Nham, et al.. (2022). Severity-Adjusted Dexamethasone Dosing and Tocilizumab Combination for Severe COVID-19. Yonsei Medical Journal. 63(5). 430–430. 7 indexed citations
19.
Nham, Eliel, Jae‐Hoon Ko, Byeong‐Ho Jeong, et al.. (2020). Severe Thrombocytopenia in a Patient with COVID-19. Infection and Chemotherapy. 52(3). 410–410. 11 indexed citations
20.
Nham, Eliel, Kyungmin Huh, Sun Young Cho, et al.. (2020). Characteristics and Clinical Outcomes of Extended-Spectrum beta-lactamase-producingKlebsiella pneumoniaeBacteremia in Cancer Patients. Infection and Chemotherapy. 52(1). 59–59. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026